Analysis of antigen involved in circulating immune complexes in patients with idiopathic thrombocytopenic purpura. 1987

Y Kurata, and S Hayashi, and H Aochi, and K Nagamine, and M Oshida, and H Mizutani, and Y Tomiyama, and T Tsubakio, and T Yonezawa, and S Tarui

Circulating immune complexes (CIC) were frequently observed in patients with idiopathic thrombocytopenic purpura (ITP). To analyse the pathogenic role of CIC, we studied the correlation between the disease activity and the CIC level, and whether platelet antigens were involved in CIC from ITP sera. Elevated CIC levels, measured by Clq, anti-C3 and spermatozoa micro-enzyme-linked immunosorbent assay, were found in 37%, 54% and 52% of the patients, respectively. However, there were no significant correlations (r = -0.11, -0.03 and -0.04, respectively) between the platelet count and the CIC level. Platelet antigens in CIC were detected with rabbit anti-human platelet serum. The CIC from 18%, 25% and 25%, respectively, of ITP sera contained platelet antigens, but the CIC from only 3%, 9% and 6% of SLE sera and from 3%, 2% and 5% of the sera of alloimmunized patients, respectively, contained these antigens. There were significant correlations (r = 0.51, 0.80 and 0.65, respectively) between the amount of platelet antigens and the CIC level in ITP sera. However, there were no correlations (r = -0.26, -0.29 and 0.08, respectively) between the platelet count and the amount of platelet antigens in the CIC. We detected platelet antigens in CIC from ITP sera, but surmise that these CIC perhaps do not play an important role in platelet destruction.

UI MeSH Term Description Entries
D007106 Immune Sera Serum that contains antibodies. It is obtained from an animal that has been immunized either by ANTIGEN injection or infection with microorganisms containing the antigen. Antisera,Immune Serums,Sera, Immune,Serums, Immune
D010976 Platelet Count The number of PLATELETS per unit volume in a sample of venous BLOOD. Blood Platelet Count,Blood Platelet Number,Platelet Number,Blood Platelet Counts,Blood Platelet Numbers,Count, Blood Platelet,Count, Platelet,Counts, Blood Platelet,Counts, Platelet,Number, Blood Platelet,Number, Platelet,Numbers, Blood Platelet,Numbers, Platelet,Platelet Count, Blood,Platelet Counts,Platelet Counts, Blood,Platelet Number, Blood,Platelet Numbers,Platelet Numbers, Blood
D011696 Purpura, Thrombocytopenic Any form of purpura in which the PLATELET COUNT is decreased. Many forms are thought to be caused by immunological mechanisms. Purpura, Thrombopenic,Purpuras, Thrombocytopenic,Purpuras, Thrombopenic,Thrombocytopenic Purpura,Thrombocytopenic Purpuras,Thrombopenic Purpura,Thrombopenic Purpuras
D001792 Blood Platelets Non-nucleated disk-shaped cells formed in the megakaryocyte and found in the blood of all mammals. They are mainly involved in blood coagulation. Platelets,Thrombocytes,Blood Platelet,Platelet,Platelet, Blood,Platelets, Blood,Thrombocyte
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000918 Antibody Specificity The property of antibodies which enables them to react with some ANTIGENIC DETERMINANTS and not with others. Specificity is dependent on chemical composition, physical forces, and molecular structure at the binding site. Antibody Specificities,Specificities, Antibody,Specificity, Antibody
D000936 Antigen-Antibody Complex The complex formed by the binding of antigen and antibody molecules. The deposition of large antigen-antibody complexes leading to tissue damage causes IMMUNE COMPLEX DISEASES. Immune Complex,Antigen-Antibody Complexes,Immune Complexes,Antigen Antibody Complex,Antigen Antibody Complexes,Complex, Antigen-Antibody,Complex, Immune,Complexes, Antigen-Antibody,Complexes, Immune
D001324 Autoantigens Endogenous tissue constituents with the ability to interact with AUTOANTIBODIES and cause an immune response. Autoantigen,Autologous Antigen,Autologous Antigens,Self-Antigen,Self-Antigens,Antigen, Autologous,Antigens, Autologous,Self Antigen,Self Antigens

Related Publications

Y Kurata, and S Hayashi, and H Aochi, and K Nagamine, and M Oshida, and H Mizutani, and Y Tomiyama, and T Tsubakio, and T Yonezawa, and S Tarui
May 1991, Vrachebnoe delo,
Y Kurata, and S Hayashi, and H Aochi, and K Nagamine, and M Oshida, and H Mizutani, and Y Tomiyama, and T Tsubakio, and T Yonezawa, and S Tarui
December 1982, British journal of haematology,
Y Kurata, and S Hayashi, and H Aochi, and K Nagamine, and M Oshida, and H Mizutani, and Y Tomiyama, and T Tsubakio, and T Yonezawa, and S Tarui
December 1986, Recenti progressi in medicina,
Y Kurata, and S Hayashi, and H Aochi, and K Nagamine, and M Oshida, and H Mizutani, and Y Tomiyama, and T Tsubakio, and T Yonezawa, and S Tarui
April 1977, Clinical and experimental immunology,
Y Kurata, and S Hayashi, and H Aochi, and K Nagamine, and M Oshida, and H Mizutani, and Y Tomiyama, and T Tsubakio, and T Yonezawa, and S Tarui
March 1978, Blood,
Y Kurata, and S Hayashi, and H Aochi, and K Nagamine, and M Oshida, and H Mizutani, and Y Tomiyama, and T Tsubakio, and T Yonezawa, and S Tarui
October 1978, Blood,
Y Kurata, and S Hayashi, and H Aochi, and K Nagamine, and M Oshida, and H Mizutani, and Y Tomiyama, and T Tsubakio, and T Yonezawa, and S Tarui
August 1977, Gaceta medica de Mexico,
Y Kurata, and S Hayashi, and H Aochi, and K Nagamine, and M Oshida, and H Mizutani, and Y Tomiyama, and T Tsubakio, and T Yonezawa, and S Tarui
January 1980, Clinical and experimental immunology,
Y Kurata, and S Hayashi, and H Aochi, and K Nagamine, and M Oshida, and H Mizutani, and Y Tomiyama, and T Tsubakio, and T Yonezawa, and S Tarui
January 1983, Haematologica,
Y Kurata, and S Hayashi, and H Aochi, and K Nagamine, and M Oshida, and H Mizutani, and Y Tomiyama, and T Tsubakio, and T Yonezawa, and S Tarui
April 2014, Haematologica,
Copied contents to your clipboard!